The Collaboration Will Leverage Innovative Technology Platforms to Help Pharma Companies Develop Drugs Faster, More Efficiently and With Higher Success Rates January 27, 2021 07:01 AM Eastern Standard Time IRVINE, Calif...read more
Category - Drug discovery
Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
Project aims to standardize MRD data generation, assessment and accelerate AML clinical trial programs bringing novel therapies to patients in need faster SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — Invitae...read more
QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute
Exclusive sales, marketing, support and distribution by QIAGEN Including over 71 million cancer mutations, the COSMIC Database joins QIAGENs’ portfolio for cancer genomic analysis and interpretation Agreement effective...read more
Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics
Capital raised will scale the Tapestri Platform to advance the development of precision medicine through improved biomarker discovery and drug development SOUTH SAN FRANCISCO, Calif. (August 13, 2020) Mission Bio, Inc...read more
